News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
443,501 Results
Type
Article (27902)
Company Profile (117)
Press Release (415482)
Multimedia
Podcasts (15)
Webinars (7)
Section
Business (123613)
Career Advice (1497)
Deals (24737)
Drug Delivery (55)
Drug Development (58765)
Employer Resources (65)
FDA (10809)
Job Trends (9821)
News (220623)
Policy (19609)
Tag
Academia (1489)
Accelerated approval (3)
Adcomms (9)
Allergies (62)
Alliances (27207)
ALS (63)
Alzheimer's disease (870)
Antibody-drug conjugate (ADC) (71)
Approvals (10866)
Artificial intelligence (139)
Autoimmune disease (17)
Automation (7)
Bankruptcy (196)
Best Places to Work (7907)
BIOSECURE Act (5)
Biosimilars (60)
Biotechnology (89)
Bladder cancer (65)
Brain cancer (18)
Breast cancer (225)
Cancer (1720)
Cardiovascular disease (123)
Career advice (1286)
Career pathing (14)
CAR-T (102)
Cell therapy (304)
Cervical cancer (15)
Clinical research (48772)
Collaboration (486)
Company closure (2)
Compensation (309)
Complete response letters (10)
COVID-19 (1659)
CRISPR (28)
C-suite (135)
Cystic fibrosis (78)
Data (1931)
Decentralized trials (2)
Denatured (1)
Depression (38)
Diabetes (190)
Diagnostics (4002)
Digital health (12)
Diversity (2)
Diversity, equity & inclusion (16)
Drug discovery (75)
Drug pricing (65)
Drug shortages (10)
Duchenne muscular dystrophy (73)
Earnings (63484)
Editorial (24)
Employer branding (12)
Employer resources (62)
Events (71912)
Executive appointments (367)
FDA (11800)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (444)
Gene editing (74)
Generative AI (14)
Gene therapy (216)
GLP-1 (460)
Government (2355)
Grass and pollen (3)
Guidances (136)
Healthcare (11761)
Huntington's disease (12)
IgA nephropathy (23)
Immunology and inflammation (80)
Indications (29)
Infectious disease (1756)
Inflammatory bowel disease (108)
Inflation Reduction Act (6)
Influenza (36)
Intellectual property (71)
Interviews (240)
IPO (13063)
IRA (27)
Job creations (2264)
Job search strategy (1103)
Kidney cancer (9)
Labor market (26)
Layoffs (269)
Leadership (7)
Legal (4223)
Liver cancer (42)
Lung cancer (236)
Lymphoma (117)
Machine learning (6)
Management (20)
Manufacturing (174)
MASH (54)
Medical device (8063)
Medtech (8064)
Mergers & acquisitions (12197)
Metabolic disorders (473)
Multiple sclerosis (66)
NASH (12)
Neurodegenerative disease (56)
Neuropsychiatric disorders (16)
Neuroscience (1237)
NextGen: Class of 2025 (3673)
Non-profit (2452)
Now hiring (12)
Obesity (236)
Opinion (114)
Ovarian cancer (65)
Pain (64)
Pancreatic cancer (57)
Parkinson's disease (100)
Partnered (9)
Patents (167)
Patient recruitment (84)
Peanut (33)
People (27775)
Pharmaceutical (28)
Pharmacy benefit managers (6)
Phase I (14660)
Phase II (21380)
Phase III (16593)
Pipeline (1143)
Policy (80)
Postmarket research (2095)
Preclinical (5962)
Press Release (57)
Prostate cancer (84)
Psychedelics (23)
Radiopharmaceuticals (172)
Rare diseases (269)
Real estate (3566)
Recruiting (29)
Regulatory (14400)
Reports (18)
Research institute (1284)
Resumes & cover letters (234)
Rett syndrome (4)
RNA editing (2)
RSV (31)
Schizophrenia (48)
Series A (72)
Series B (43)
Service/supplier (6)
Sickle cell disease (35)
Special edition (10)
Spinal muscular atrophy (122)
Sponsored (16)
Startups (1926)
State (1)
Stomach cancer (8)
Supply chain (31)
Tariffs (29)
The Weekly (13)
Vaccines (454)
Venture capitalists (23)
Weight loss (136)
Women's health (17)
Worklife (7)
Date
Today (197)
Last 7 days (697)
Last 30 days (2158)
Last 365 days (22898)
2025 (8067)
2024 (24419)
2023 (26936)
2022 (33207)
2021 (36174)
2020 (34451)
2019 (28212)
2018 (20921)
2017 (19859)
2016 (18369)
2015 (22363)
2014 (15905)
2013 (11867)
2012 (12790)
2011 (13757)
2010 (12091)
Location
Africa (554)
Alabama (46)
Alaska (1)
Arizona (142)
Arkansas (4)
Asia (24794)
Australia (4111)
California (4490)
Canada (1229)
China (349)
Colorado (171)
Connecticut (199)
Delaware (118)
Europe (57558)
Florida (696)
Georgia (138)
Idaho (24)
Illinois (371)
India (16)
Indiana (242)
Iowa (7)
Japan (112)
Kansas (69)
Kentucky (11)
Louisiana (7)
Maine (60)
Maryland (574)
Massachusetts (3146)
Michigan (105)
Minnesota (230)
Mississippi (1)
Missouri (43)
Montana (12)
Nebraska (6)
Nevada (47)
New Hampshire (32)
New Jersey (1451)
New Mexico (7)
New York (1382)
North Carolina (689)
North Dakota (3)
Northern California (2014)
Ohio (120)
Oklahoma (4)
Oregon (12)
Pennsylvania (1046)
Puerto Rico (10)
Rhode Island (17)
South America (751)
South Carolina (16)
South Dakota (1)
Southern California (1732)
Tennessee (63)
Texas (685)
United States (16721)
Utah (134)
Virginia (106)
Washington D.C. (42)
Washington State (434)
West Virginia (3)
Wisconsin (30)
443,501 Results for "10".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
10x Genomics Reports First Quarter 2025 Financial Results
May 9, 2025
·
10 min read
Press Releases
Cipher Surgical Completes $10 Million Series A Funding Round
April 28, 2025
·
2 min read
Press Releases
10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference
May 1, 2025
·
1 min read
Press Releases
Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive
May 7, 2025
·
4 min read
Press Releases
Uniphar Secures 10th Cell and Gene Therapy Project
April 22, 2025
·
3 min read
Deals
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
November 26, 2024
·
2 min read
·
Kate Goodwin
Job Creations
Massachusetts Increases Life Sciences Investment by $500M Over 10 Years
Massachusetts’ increased investment in the life sciences industry includes boosting its life sciences tax incentive program by $10 million annually, aiding job creation in the state.
November 21, 2024
·
2 min read
·
Angela Gabriel
Press Releases
Cantargia Announces Selection of Treatment Resistant Atopic Dermatitis as Second Target Indication for CAN10
April 29, 2025
·
4 min read
Press Releases
Kedrion Biopharma closes 2024 with a growth of +10% and unveils its new identity
April 14, 2025
·
6 min read
Press Releases
BeyondSpring Files 2024 Annual Report on Form 10-K
March 28, 2025
·
2 min read
1 of 44,351
Next
